Combining network pharmacology, machine learning, molecular docking, molecular simulation dynamics and experimental validation to explore the mechanism of Zhenwu decoction in treating major depression through TNF-α pathways
Behavioural Brain Research · 2026
DOI: 10.1016/j.bbr.2025.115997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2026. Verfasst von Xinyu Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Psychology and Ethics, School of Basic Medicine Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Major Depressive Disorder, Antidepressive Agents, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China.
Themen: Künstliche Intelligenz in der Pflege, Depression, Simulation in der Pflegeausbildung
Abstract (Originalsprache)
BACKGROUND: Major depressive disorder (MDD) is a severe psychophysiological condition characterized by cognitive decline, low energy, weight loss, insomnia, and increased suicide risk, posing a significant burden on global health. Zhenwu decoction (ZWD), a traditional Chinese medicine, has shown therapeutic potential in alleviating MDD symptoms. However, its complex composition has limited the understanding of its underlying pharmacological mechanisms. This study aimed to explore the antidepressant mechanisms of ZWD in the treatment of MDD. METHODS: Active compounds and potential targets of ZWD were identified through database screening and network pharmacology analysis. These targets were intersected with MDD-related genes to construct a protein-protein interaction network. Core targets were further refined using random forest algorithms. Molecular docking and molecular dynamics simulations were employed to evaluate the binding affinity and stability between key compounds and core targets. Experimental validation was conducted in a lipopolysaccharide (LPS)-induced mice model of depression using behavioral testing, measurement of inflammatory cytokines, and gene expression analysis. RESULTS: Network pharmacology and machine learning identified TNF-α signaling as key pathways in the antidepressant effects of ZWD. Enrichment analysis highlighted the involvement of Lipid and atherosclerosis, the IL-17 signaling pathway. Core targets, including PPARG, F10, AR, TNF, PIK3CG, ADH1C, and GABRA6, were predicted to mediate its effects. Molecular docking and dynamics simulations confirmed strong binding of ZWD components, especially kaempferol, to TNF-α, inhibiting its expression. In vivo, ZWD improved anxiety/depressive-like behaviors in LPS-treated mice, evidenced by better performance in the behavioral tests. ZWD also reduced neuroinflammation, with decreased Tnf-α levels, and reduced IBA-1 and GFAP staining, indicating reduced microglial and astrocyte activation. These results suggest that ZWD alleviates depression through modulation of TNF-α-mediated inflammation. CONCLUSIONS: These findings suggest that ZWD exerts antidepressant effects primarily by modulating TNF-α-mediated inflammatory pathways, providing a comprehensive molecular and experimental framework supporting its clinical potential in MDD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Psychology and Ethics, School of Basic Medicine Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, PR China.
- Department of Burn, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), Qingdao, Shandong 266300, PR China.
- Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, PR China.
- Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, PR China. Electronic address: wangzhen@sdu.edu.cn.
- Department of Medical Psychology and Ethics, School of Basic Medicine Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, PR China. Electronic address: liudexiang@sdu.edu.cn.
Förderung
- Shandong Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhou, X., Gao, Y., Liu, S., Zhao, Y., Wang, Z., & Liu, D. (2026). Combining network pharmacology, machine learning, molecular docking, molecular simulation dynamics and experimental validation to explore the mechanism of Zhenwu decoction in treating major depression through TNF-α pathways. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2025.115997
Vancouver
Zhou X, Gao Y, Liu S, Zhao Y, Wang Z, Liu D. Combining network pharmacology, machine learning, molecular docking, molecular simulation dynamics and experimental validation to explore the mechanism of Zhenwu decoction in treating major depression through TNF-α pathways. Behavioural Brain Research. 2026. doi:10.1016/j.bbr.2025.115997
BibTeX
@article{Zhou2026,
author = {Zhou, Xinyu and Gao, Yan and Liu, Sashuang and Zhao, Yijing and Wang, Zhen and Liu, Dexiang},
title = {Combining network pharmacology, machine learning, molecular docking, molecular simulation dynamics and experimental validation to explore the mechanism of Zhenwu decoction in treating major depression through TNF-α pathways},
journal = {Behavioural Brain Research},
year = {2026},
doi = {10.1016/j.bbr.2025.115997}
}
EUVIMED